Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Current Atherosclerosis Reports
Published in: Current Atherosclerosis Reports 6/2010

01-11-2010 | Clinical Trial Report

Marine Omega-3 Fatty Acids and Plaque Stabilization

Author: William S. Harris

Published in: Current Atherosclerosis Reports | Issue 6/2010

Login to get access

Excerpt

Cawood AL, Ding R, Napper FL, et al.: Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability. Atherosclerosis 2010 (in press). …
Literature
1.
Thies F, Garry JM, Yaqoob P, et al.: Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet 2003, 361:477–485.CrossRefPubMed
Metadata
Title
Marine Omega-3 Fatty Acids and Plaque Stabilization
Author
William S. Harris
Publication date
01-11-2010
Publisher
Current Science Inc.
Published in
Current Atherosclerosis Reports / Issue 6/2010
Print ISSN: 1523-3804
Electronic ISSN: 1534-6242
DOI
https://doi.org/10.1007/s11883-010-0129-0

Other articles of this Issue 6/2010

Current Atherosclerosis Reports 6/2010 Go to the issue

ReviewPaper

Coenzyme Q10 and Statin Myalgia: What is the Evidence?

ReviewPaper

Nuts and Berries for Heart Health

ReviewPaper

Revisiting Dietary Cholesterol Recommendations: Does the Evidence Support a Limit of 300 mg/d?

ReviewPaper

Effects of Whole Grains on Coronary Heart Disease Risk

ReviewPaper

Strategies in Stable Ischemic Heart Disease: Lessons from the COURAGE and BARI-2D Trials

ReviewPaper

Alpha-Linolenic Acid: Is It Essential to Cardiovascular Health?

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits